Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
about
Screening from the world's largest TCM database against H1N1 virus.Structure and stability analysis of cytotoxic complex of camel α-lactalbumin and unsaturated fatty acids produced at high temperature.Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database.In search of allosteric modulators of a7-nAChR by solvent density guided virtual screening.Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving.Virus-mPLoc: a fusion classifier for viral protein subcellular location prediction by incorporating multiple sites.Biological evaluation and interaction of a newly designed anti-cancer Pd(II) complex and human serum albumin.Anti-infectious bronchitis virus (IBV) activity of 1,8-cineole: effect on nucleocapsid (N) protein.Molecular modeling studies of Yersinia pestis dihydrofolate reductase.Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus.Molecular modeling of Mycobacterium tuberculosis dUTpase: docking and catalytic mechanism studies.Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.Docking and molecular dynamics studies of peptide inhibitors of ornithine decarboxylase: a rate-limiting enzyme for the metabolism of Fusarium solani.Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis.Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design.Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database.Biphasic association of T7 RNA polymerase and a nucleotide analogue, cibacron blue as a model to understand the role of initiating nucleotide in the mechanism of enzyme action.BetaDock: shape-priority docking method based on beta-complex.Compounds of the 1,5-di(4-R-phenyl)- 3-selenopentanediones-1,5 series interaction with the basidiomycete Lentinula edodes lectins: computations and experiment.Melting of model HIV-1 stem-loop 1 RNA dimers monitored by 2-aminopurine fluorescence.Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitors.
P2860
Q30399346-31D15FC8-7D25-48C5-8A7A-EE4691F9F551Q30401575-A451C72E-57E4-4AC7-A41C-FDFA8F5A80FCQ33525137-10554238-EF40-4077-B018-BC844DE3DA6CQ33811917-231AC60D-1C9F-4519-8F29-D46741679192Q34351611-6BA1D2CF-2216-463D-9348-D8FBE8FD752BQ38014473-9921BA23-68E1-4E87-BB2C-F26BE245A2D2Q38505682-B5D9BD47-5A1F-4557-A663-1090E17F57CFQ39482778-7811F1D9-E477-435A-90CC-CC07897C1B7AQ39648387-F52BCA53-6614-45B9-80E1-1A1BBEBA7BFDQ41426709-8B1BBE55-C162-45DE-9D8D-F2E6A4A4DD98Q41932456-133CE768-357B-49A4-8CC6-22A9EC1B8CBDQ42964671-2FDF0327-FDB4-49A1-9D74-4E8A6D6EEA8FQ43414532-9E86D45C-3DDF-4EE7-B268-3DEF8B954A02Q43727902-5A8D78D9-F2B4-4385-9D9D-A3DAFEFAFB35Q45118651-F43B92EF-86B7-4581-9098-F3BD1B170F8FQ45330213-56BDAB32-497D-4713-BCCE-0F3FBDFC9277Q46159949-296E8133-853A-4A4D-B628-C7CF4C140234Q46477869-8C5BCEA4-A41E-42FE-BEA1-987B42E2D66DQ47269444-D9302896-21CE-4131-942F-B894FA1756D5Q47287940-4DB678CE-8784-4031-AFD4-C75545233C69Q47337151-CFC271B9-EEE4-4083-A0AF-122F1BB344AEQ50275626-FB3EC6B2-95D5-40EC-BC61-3F7A15F9768DQ51555332-12A176B0-DD38-4A01-B4F5-7CEBFA0D3E27Q51602625-9B2F6989-5D9B-4A55-9C75-8280F1CC1D68Q52609765-41605C9E-3C61-4319-B222-B8C0C0723A69Q53419138-0632FD5A-6E38-42D5-AC5E-B1D6C4BEFF41
P2860
Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Computational model of the HIV ...... e-based anti-AIDS drug design.
@en
Computational model of the HIV ...... e-based anti-AIDS drug design.
@nl
type
label
Computational model of the HIV ...... e-based anti-AIDS drug design.
@en
Computational model of the HIV ...... e-based anti-AIDS drug design.
@nl
prefLabel
Computational model of the HIV ...... e-based anti-AIDS drug design.
@en
Computational model of the HIV ...... e-based anti-AIDS drug design.
@nl
P2860
P1476
Computational model of the HIV ...... e-based anti-AIDS drug design.
@en
P2093
Alexander M Andrianov
Ivan V Anishchenko
P2860
P304
P356
10.1080/07391102.2009.10507308
P577
2009-10-01T00:00:00Z